miR-125b Enhances IL-8 Production in Early-Onset Severe Preeclampsia by Targeting Sphingosine-1-Phosphate Lyase 1

Area of Science:

• Reproductive biology
• Molecular medicine
• Inflammation research

Background:

• Preeclampsia (PE) is a major cause of maternal and perinatal mortality.
• Impaired inflammation is a hallmark of preeclampsia.
• The role of specific microRNAs in PE pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the role of microRNA-125b (miR-125b) in preeclampsia.
• To identify the molecular targets and pathways regulated by miR-125b in PE.
• To explore the association between miR-125b, SGPL1, and IL-8 in PE.

Main Methods:

• Analysis of miR-125b and SGPL1 expression in placental tissues and plasma from PE patients.
• Luciferase assays to confirm SGPL1 as a direct target of miR-125b.
• Assessment of IL-8 production in response to miR-125b and SGPL1 manipulation.

Main Results:

• miR-125b was deregulated in PE patients' placental tissues and plasma.
• miR-125b directly targets and downregulates sphingosine-1-phosphate lyase 1 (SGPL1) expression.
• miR-125b enhances IL-8 production, which was reversed by SGPL1 overexpression; increased IL-8 was observed in PE patients.

Conclusions:

• miR-125b plays a critical role in regulating IL-8 production.
• The miR-125b/SGPL1/IL-8 axis is implicated in the pathogenesis of preeclampsia.
• Targeting miR-125b may offer a therapeutic strategy for preeclampsia.